Description of the regulatory framework of the share repurchase program proposed to the Combined Shareholders’ Meeting of 27 May 2015

This article or press release has no online content. Please download the associated documents for more information.

© Ipsen Pharma, 65 Quai Georges Gorse, 92100 Boulogne-Billancourt, France. All rights reserved. - 2019